Pre-Approval Access Single Patient Request Treatment for Talquetamab for Treating Physician Use in Relapsed or Refractory Multiple Myeloma
Latest Information Update: 07 Mar 2025
At a glance
- Drugs Talquetamab (Primary)
- Indications Multiple myeloma
- Focus Expanded access; Therapeutic Use
- Sponsors Janssen Research & Development
Most Recent Events
- 07 Feb 2023 Status changed from recruiting to active, no longer recruiting.
- 18 Aug 2022 New trial record